The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?Nobumasa Takasugi, Takashi Uehara, Masato Komai et al.|Cells|2023Cited by 24
TMEM30A is a candidate interacting partner for the β-carboxyl-terminal fragment of amyloid-β precursor protein in endosomesNobumasa Takasugi, Takashi Sakurai, Taku Kashiyama et al.|PLoS ONE|2018Cited by 18
Lipid flippase dysfunction as a therapeutic target for endosomal anomalies in Alzheimer’s diseaseNanaka Kaneshiro, Nobumasa Takasugi, Masato Komai et al.|iScience|2022Cited by 17
Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytesMasato Komai, Nobumasa Takasugi, Yuka Noda et al.|Journal of Lipid Research|2024Cited by 10
Lipid flippase dysfunction as a novel therapeutic target for endosomal anomalies in Alzheimer’s diseaseNanaka Kaneshiro, Nobumasa Takasugi, Masato Komai et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0